nano-eggshell varnish
Preclinical
nano-eggshell varnish is one of 9 therapeutic programs targeting Dental Caries. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
8 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Approved
Betadine
BBecton, Dickinson and Company
Approved
Mycostatin
GGood Molecules, LLC
Approved
Zocor
OOrganon and Co
Approved
KH001
HHysensBio Co., Ltd
Phase 2
Chlorhexidine Digluconate
GSKPreclinical
Nano Silver Fluoride
OOctober University for Modern Sciences and Arts
Preclinical
Vancomycin Hydrochloride
WWake Forest University Health Sciences
Preclinical
nano-eggshell varnish
MMansoura University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Dental Caries1 trial
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for nano-eggshell varnish. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]
- Company
- MMansoura University